Vitality Watch

⚠ Evidence note: Mechanistic aging biology translates to human interventions slowly and unreliably; model-organism lifespan gains have repeatedly failed to transfer.

Mentioned 1× · first seen 09-sep-2026 · last seen 09-sep-2026

YAP1/Hippo Signaling in Senescence and Fibrosis

Current understanding

To be populated as evidence accumulates.

Evidence log

  • 2026-09-24 — The mechanisms and mechanics of aging.: cross-connection with mechanotransduction-aging: Positions YAP/TAZ dysregulation as the transcriptional endpoint of a matrix-to-nucleus mechanical relay that fails with age, linking Hippo-pathway senescence biology to the ECM/cytoskeleton mechanics side of the field. (novelty: 3)
  • 2026-07-01 — Targeting YAP1-Mediated Tubular Cell Senescence to Attenuate Maladaptive Repair and Fibrotic Transition After Acute Kidney Injury.: 2026 preclinical AKI study: sustained tubular YAP1 overexpression drives cellular senescence and maladaptive repair after acute kidney injury; post-injury senolytics (D+Q) or the YAP–TEAD inhibitor verteporfin suppress YAP1 activity and senescence markers and attenuate progression to renal fibrosis in mouse AKI-to-CKD models — nominates YAP1 as a druggable node coupling mechanotransduction to tubular senescence, mouse-only. [animal-model] (novelty: 3)

Open questions

Related

Contributing findings

pubmed preclinical animal-model
Targeting YAP1-Mediated Tubular Cell Senescence to Attenuate Maladaptive Repair and Fibrotic Transition After Acute Kidney Injury.
01-jul-2026 novelty 3 per-area 3 strengthens

build build 880 · 2bcef25 · 2026-11-18